צמיחה צפויה ברווח למניה לשנה הבאה nanovibronix.com (NAOV)

Diversification into urology and surgery reduces regulatory risks for NanoVibronix, Inc. (NAOV), which supports the modeled EPS growth for the next fiscal year; the data consistency on the GURU.Markets chart demonstrates this trend, and the value of 0.00 captures this metric. Revenues are based on the sale of ultrasound systems for wound healing. Environmental policy is limited to energy saving and plastic recycling.
פילוחים אנליטיים של חברת NanoVibronix (NAOV)

This indicator measures the consensus earnings per share (EPS) growth forecast, reflecting market expectations regarding the issuer's future performance and its resilience to macroeconomic shocks. By analyzing the next year's EPS growth estimates on the GURU.Markets platform, an investor can assess how the diversified logistics of NanoVibronix, Inc. (NAOV) impact margin stability and protect profits from component supply chain disruptions.